X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (506) 506
Patent (469) 469
Paper (102) 102
Publication (85) 85
Conference Proceeding (31) 31
Book / eBook (26) 26
Book Chapter (4) 4
Dissertation (2) 2
Magazine Article (2) 2
Book Review (1) 1
Streaming Audio (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (230) 230
index medicus (121) 121
performing operations (119) 119
transporting (119) 119
experiment (106) 106
particle physics (102) 102
chemistry (98) 98
high energy physics - experiment (95) 95
humans (95) 95
metallurgy (91) 91
physics - high energy physics - experiment (90) 90
electricity (86) 86
measuring (77) 77
testing (77) 77
female (71) 71
oncology (60) 60
middle aged (58) 58
electric communication technique (52) 52
physical sciences (51) 51
aged (50) 50
fysik (50) 50
natural sciences (49) 49
naturvetenskap (49) 49
male (48) 48
high energy physics (47) 47
human necessities (47) 47
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (46) 46
telephonic communication (46) 46
adult (45) 45
analysis (43) 43
heating (40) 40
transmission of digital information, e.g. telegraphiccommunication (40) 40
blasting (39) 39
lighting (39) 39
mechanical engineering (39) 39
weapons (39) 39
subatomär fysik (37) 37
selecting (36) 36
subatomic physics (36) 36
treatment outcome (36) 36
chemotherapy (33) 33
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
fixed constructions (32) 32
cancer (30) 30
calculating (29) 29
computing (29) 29
counting (29) 29
nuclear experiment (29) 29
hygiene (28) 28
medical or veterinary science (28) 28
animals (27) 27
disease-free survival (27) 27
double-blind method (27) 27
care and treatment (26) 26
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (26) 26
metastasis (26) 26
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (26) 26
machine tools (25) 25
metal-working not otherwise provided for (25) 25
phenomenology (25) 25
research (25) 25
antineoplastic combined chemotherapy protocols - adverse effects (24) 24
breast neoplasms - drug therapy (24) 24
geophysics (24) 24
physics of elementary particles and fields (24) 24
detecting masses or objects (23) 23
gravitational measurements (23) 23
metallurgy of iron (23) 23
clinical trials (22) 22
particle physics - experiment (22) 22
breast cancer (20) 20
general tagging of cross-sectional technologies spanning over several sections of the ipc (20) 20
general tagging of new technological developments (20) 20
physics, particles & fields (20) 20
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (20) 20
technologies or applications for mitigation or adaptation againstclimate change (20) 20
aged, 80 and over (19) 19
kaplan-meier estimate (19) 19
investigating or analysing materials by determining theirchemical or physical properties (18) 18
manufacture of iron or steel (18) 18
electric techniques not otherwise provided for (17) 17
ferrous or non-ferrous alloys (17) 17
survival (17) 17
treatment of alloys or non-ferrous metals (17) 17
breast neoplasms - pathology (16) 16
cladding or plating by soldering or welding (16) 16
cutting by applying heat locally, e.g. flame cutting (16) 16
earth drilling (16) 16
elementary particles, quantum field theory (16) 16
mining (16) 16
quantum field theories, string theory (16) 16
soldering or unsoldering (16) 16
welding (16) 16
working by laser beam (16) 16
antineoplastic agents - therapeutic use (15) 15
hematology, oncology and palliative medicine (15) 15
measuring electric variables (15) 15
measuring magnetic variables (15) 15
mechanical metal-working without essentially removingmaterial (15) 15
melanoma (15) 15
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
UTL at Downsview - May be requested (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Stacks (3) 3
Engineering & Comp. Sci. - Stacks (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Physics - Stacks (1) 1
Robarts - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (988) 988
Russian (240) 240
German (29) 29
French (27) 27
Polish (2) 2
Chinese (1) 1
Japanese (1) 1
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 25 - 35
Summary Background Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with preclinical evidence of... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EXEMESTANE | ONCOLOGY | CELL-CYCLE | POSTMENOPAUSAL WOMEN | HER2 | PLUS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Triazoles - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Molecular Targeted Therapy | North America | Nitriles - administration & dosage | Breast Neoplasms - enzymology | Time Factors | Postmenopause | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Republic of Korea | Aromatase Inhibitors - administration & dosage | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Europe | Proportional Hazards Models | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Treatment Outcome | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | South Africa | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Research | Antineoplastic agents | Phosphotransferases | Cancer
Journal Article
European Physical Journal C, ISSN 1434-6044, 2012, Volume 72, Issue 1, pp. 1 - 61
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 143 - 155
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9992, pp. 444 - 451
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10063, pp. 2997 - 3005
Journal Article
1976, Novʹ donskai͡a, 284
Book
1984, Novinki "Sovremennika", 221 p. --
Book